Business Description
RepliCel Life Sciences Inc
NAICS : 541715
SIC : 3741
ISIN : CA76027P4006
Description
RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles. Also, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company use autologous cell therapy which is developed for the treatment of androgenetic alopecia. The revenue is generated from Licensing fees.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | -20.05 | |||||
| Debt-to-Equity | -0.01 | |||||
| Debt-to-EBITDA | -0.62 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -195.75 | |||||
| Beneish M-Score | 6.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15.7 | |||||
| 3-Year EBITDA Growth Rate | 46.6 | |||||
| 3-Year EPS without NRI Growth Rate | 63 | |||||
| 3-Year FCF Growth Rate | 31.5 | |||||
| 3-Year Book Growth Rate | 7.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.28 | |||||
| 9-Day RSI | 39.05 | |||||
| 14-Day RSI | 42.62 | |||||
| 6-1 Month Momentum % | -26.67 | |||||
| 12-1 Month Momentum % | -62.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.13 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.9 | |||||
| Shareholder Yield % | -38 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -388.92 | |||||
| Net Margin % | -19.6 | |||||
| FCF Margin % | -565.91 | |||||
| ROA % | -10.9 | |||||
| ROIC % | -111.36 | |||||
| ROC (Joel Greenblatt) % | -3777.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | 3.93 | |||||
| PEG Ratio | 0.11 | |||||
| PS Ratio | 9.17 | |||||
| EV-to-EBIT | -52.71 | |||||
| EV-to-EBITDA | -54.3 | |||||
| EV-to-Revenue | 10.18 | |||||
| EV-to-FCF | -1.8 | |||||
| Earnings Yield (Greenblatt) % | -1.9 | |||||
| FCF Yield % | -55.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RepliCel Life Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.352 | ||
| EPS (TTM) (C$) | 0 | ||
| Beta | -0.08 | ||
| Volatility % | 67.93 | ||
| 14-Day RSI | 42.62 | ||
| 14-Day ATR (C$) | 0.000436 | ||
| 20-Day SMA (C$) | 0.055 | ||
| 12-1 Month Momentum % | -62.07 | ||
| 52-Week Range (C$) | 0.04 - 0.25 | ||
| Shares Outstanding (Mil) | 65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RepliCel Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RepliCel Life Sciences Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
RepliCel Life Sciences Inc Frequently Asked Questions
What is RepliCel Life Sciences Inc(TSXV:RP)'s stock price today?
The current price of TSXV:RP is C$0.06. The 52 week high of TSXV:RP is C$0.25 and 52 week low is C$0.04.
When is next earnings date of RepliCel Life Sciences Inc(TSXV:RP)?
The next earnings date of RepliCel Life Sciences Inc(TSXV:RP) is .
Does RepliCel Life Sciences Inc(TSXV:RP) pay dividends? If so, how much?
RepliCel Life Sciences Inc(TSXV:RP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers